IBDEI11C ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18556,2)
 ;;=^272742
 ;;^UTILITY(U,$J,358.3,18557,0)
 ;;=754.53^^121^1177^8
 ;;^UTILITY(U,$J,358.3,18557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18557,1,3,0)
 ;;=3^754.53
 ;;^UTILITY(U,$J,358.3,18557,1,5,0)
 ;;=5^Metatarsal adductus/varus; Congenital
 ;;^UTILITY(U,$J,358.3,18557,2)
 ;;=^273007
 ;;^UTILITY(U,$J,358.3,18558,0)
 ;;=355.8^^121^1177^9
 ;;^UTILITY(U,$J,358.3,18558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18558,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,18558,1,5,0)
 ;;=5^Mononeuritis of lower limb, unspecified
 ;;^UTILITY(U,$J,358.3,18558,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,18559,0)
 ;;=729.1^^121^1177^11
 ;;^UTILITY(U,$J,358.3,18559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18559,1,3,0)
 ;;=3^729.1
 ;;^UTILITY(U,$J,358.3,18559,1,5,0)
 ;;=5^Myalgia and myositis, unspecified
 ;;^UTILITY(U,$J,358.3,18559,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,18560,0)
 ;;=355.71^^121^1178^4
 ;;^UTILITY(U,$J,358.3,18560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18560,1,3,0)
 ;;=3^355.71
 ;;^UTILITY(U,$J,358.3,18560,1,5,0)
 ;;=5^Nerve entrapment, lower limb
 ;;^UTILITY(U,$J,358.3,18560,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,18561,0)
 ;;=216.7^^121^1178^2
 ;;^UTILITY(U,$J,358.3,18561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18561,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,18561,1,5,0)
 ;;=5^Neoplasm, skin of lower limb, including hip; Benign
 ;;^UTILITY(U,$J,358.3,18561,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,18562,0)
 ;;=239.2^^121^1178^3
 ;;^UTILITY(U,$J,358.3,18562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18562,1,3,0)
 ;;=3^239.2
 ;;^UTILITY(U,$J,358.3,18562,1,5,0)
 ;;=5^Neoplasm, skin, bone and soft tissue; Unspecified
 ;;^UTILITY(U,$J,358.3,18562,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,18563,0)
 ;;=356.9^^121^1178^7
 ;;^UTILITY(U,$J,358.3,18563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18563,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,18563,1,5,0)
 ;;=5^Neuropathy, peripheral, Hereditary; Unspecified
 ;;^UTILITY(U,$J,358.3,18563,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,18564,0)
 ;;=355.8^^121^1178^8
 ;;^UTILITY(U,$J,358.3,18564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18564,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,18564,1,5,0)
 ;;=5^Neuropathy, peripheral, lower limb; Unspecified
 ;;^UTILITY(U,$J,358.3,18564,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,18565,0)
 ;;=356.2^^121^1178^5
 ;;^UTILITY(U,$J,358.3,18565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18565,1,3,0)
 ;;=3^356.2
 ;;^UTILITY(U,$J,358.3,18565,1,5,0)
 ;;=5^Neuropathy, Hereditary sensory
 ;;^UTILITY(U,$J,358.3,18565,2)
 ;;=^56583
 ;;^UTILITY(U,$J,358.3,18566,0)
 ;;=714.0^^121^1178^9
 ;;^UTILITY(U,$J,358.3,18566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18566,1,3,0)
 ;;=3^714.0
 ;;^UTILITY(U,$J,358.3,18566,1,5,0)
 ;;=5^Nodules, rheumatoid arthritis
 ;;^UTILITY(U,$J,358.3,18566,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,18567,0)
 ;;=733.82^^121^1178^10
 ;;^UTILITY(U,$J,358.3,18567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18567,1,3,0)
 ;;=3^733.82
 ;;^UTILITY(U,$J,358.3,18567,1,5,0)
 ;;=5^Nonunion of fracture
 ;;^UTILITY(U,$J,358.3,18567,2)
 ;;=^83875
 ;;^UTILITY(U,$J,358.3,18568,0)
 ;;=173.70^^121^1178^1
 ;;^UTILITY(U,$J,358.3,18568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18568,1,3,0)
 ;;=3^173.70
 ;;^UTILITY(U,$J,358.3,18568,1,5,0)
 ;;=5^Neoplasm, Skin Lower Limb
 ;;^UTILITY(U,$J,358.3,18568,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,18569,0)
 ;;=356.8^^121^1178^6
 ;;^UTILITY(U,$J,358.3,18569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18569,1,3,0)
 ;;=3^356.8
 ;;^UTILITY(U,$J,358.3,18569,1,5,0)
 ;;=5^Neuropathy, Idiopathic Perip,Oth Spec
